Overall, it may be hypothesised that whereas T lymphocytes could have a more prominent role in sPD etiopathogenesis, inflammation in LRRK2-PD could be mediated through circulating inflammatory mediators rather than through a T cell dysregulation. This evidence concerns the gene LRRK2 and Parkinson disease.